Volume 95 Issue 2 | p. 13 | Concentrates
Issue Date: January 9, 2017

Lilly, Bayer help animal health deal

Department: Business
Keywords: agriculture, crop protection chemicals, imaging
[+]Enlarge
Lilly is acquiring a portfolio that includes vaccines for pets.
Credit: Shutterstock
A photo of a dog receiving an injection.
 
Lilly is acquiring a portfolio that includes vaccines for pets.
Credit: Shutterstock

Eli Lilly & Co. has spent $885 million to buy three animal vaccine product lines in the U.S. from Boehringer Ingelheim, along with a manufacturing and R&D site. Meanwhile, Bayer is acquiring two parasite control products. The U.S. Federal Trade Commission required Boehringer to divest the businesses to complete a $13.5 billion swap of its consumer health business for Sanofi’s animal health subsidiary Merial on Jan 1. Last year, France’s Ceva Santé Animale bought nine Merial products to address European regulatory concerns.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment